Back to Search
JACQUES GALIPEAU, MD FRCP
MD FRCP
Hematology & Oncology Physician
NPI: 1629307004IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
66345(WI)
CMS Specialties
PrimaryHEMATOLOGY/ONCOLOGY
Education
OTHER
Class of 1988
Research & Publications (20)
Mesenchymal stromal cells ameliorate experimental autoimmune encephalomyelitis by inhibiting CD4 Th17 T cells in a CC chemokine ligand 2-dependent manner.
PMID 19414750·J Immunol·2009
7-preclinical
Three-dimensional porous scaffolds at the crossroads of tissue engineering and cell-based gene therapy.
PMID 19681040·J Cell Biochem·2009
6-review
A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties.
PMID 19668193·Nat Med·2009
7-preclinical
Autologous bone marrow stromal cells genetically engineered to secrete an igf-I receptor decoy prevent the growth of liver metastases.
PMID 19367255·Mol Ther·2009
7-preclinical
Mesenchymal stromal cells cross-present soluble exogenous antigens as part of their antigen-presenting cell properties.
PMID 19654411·Blood·2009
7-preclinical
The stem cell research environment: a patchwork of patchworks.
PMID 19521798·Stem Cell Rev Rep·2009
6-review
Cytokine modulation of TLR expression and activation in mesenchymal stromal cells leads to a proinflammatory phenotype.
PMID 19494321·J Immunol·2009
7-preclinical
Allogeneic mesenchymal stem cells for treatment of experimental autoimmune encephalomyelitis.
PMID 19602999·Mol Ther·2009
7-preclinical
An engineered GM-CSF-CCL2 fusokine is a potent inhibitor of CCR2-driven inflammation as demonstrated in a murine model of inflammatory arthritis.
PMID 19592643·J Immunol·2009
7-preclinical
Improved autograft survival of mesenchymal stromal cells by plasminogen activator inhibitor 1 inhibition.
PMID 19338064·Stem Cells·2009
7-preclinical
Selective inhibition of CCR2 expressing lymphomyeloid cells in experimental autoimmune encephalomyelitis by a GM-CSF-MCP1 fusokine.
PMID 19234156·J Immunol·2009
7-preclinical
Characterization of Gaucher disease bone marrow mesenchymal stromal cells reveals an altered inflammatory secretome.
PMID 19587377·Blood·2009
8-other
Catalyzing umbilical cord blood research in Canada: a survey of current needs and practices of principal investigators.
PMID 19208286·J Obstet Gynaecol Can·2009
8-other
Bone marrow mesenchymal stromal cells of patients with myeloproliferative disorders do not carry the JAK2-V617F mutation.
PMID 19135773·Exp Hematol·2009
8-other
Mesenchymal stromal cells engineered to express erythropoietin induce anti-erythropoietin antibodies and anemia in allorecipients.
PMID 19088705·Mol Ther·2009
7-preclinical
Enzyme replacement therapy in pediatric patients with Gaucher disease: what should we use as maintenance dosage?
PMID 19083253·Mol Genet Metab·2009
8-other
Evidence for transcriptional regulation of the glucose-6-phosphate transporter by HIF-1alpha: Targeting G6PT with mumbaistatin analogs in hypoxic mesenchymal stromal cells.
PMID 19074414·Stem Cells·2009
7-preclinical
The carboxylation efficiency of the vitamin K-dependent clotting factors: studies with factor IX.
PMID 18680528·Haemophilia·2008
8-other
Mesenchymal stromal cell-derived CCL2 suppresses plasma cell immunoglobulin production via STAT3 inactivation and PAX5 induction.
PMID 18812467·Blood·2008
7-preclinical
Design and fabrication of 3D porous scaffolds to facilitate cell-based gene therapy.
PMID 19230126·Tissue Eng Part A·2008
7-preclinical
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 600 HIGHLAND AVE
MADISON, WI 53792 - Phone
- (608) 265-1700
Quick Facts
- NPI
- 1629307004
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 38
- Publications
- 20
Are you this provider?
Claim Your Profile